Last update 28 Mar 2025

Pegulicianine

Overview

Basic Info

Drug Type
Polymer, Fluorescent dyes
Synonyms
Pegulicianine acetate, LUM 015, LUM-015
+ [1]
Target
Action
inhibitors
Mechanism
Cathepsin inhibitors, Diagnostic dye
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
United States (17 Apr 2024),
RegulationFast Track (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC122H159N19O27S4
InChIKeyWXYGTEQQRMLSJY-UHFFFAOYSA-N
CAS Registry2230217-18-0

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Breast Cancer
United States
17 Apr 2024
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Invasive Mammary CarcinomaPhase 2
United States
01 Sep 2020
Adenocarcinoma of prostatePhase 2
United States
20 Mar 2019
Secondary malignant neoplasm of peritoneumPhase 2
United States
18 Mar 2019
Colorectal CancerPhase 2
United States
04 Aug 2016
Early gastric cancerPhase 2
United States
04 Aug 2016
Esophageal CarcinomaPhase 2
United States
04 Aug 2016
Pancreatic CancerPhase 2
United States
04 Aug 2016
Brain metastasesClinical
United States
03 May 2019
GlioblastomaClinical
United States
03 May 2019
IDH1-mutant GliomaClinical
United States
03 May 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
357
cpwkinveeq(lasplizsbi) = qbhpqomlhr uuptozaydp (xjixlqimef, 5.0 - 10.8)
Positive
17 Apr 2024
Phase 3
406
Study Device Arm
(Device Intervention: LUM Imaging System Used During Surgery)
qyfegafinn = vlaaqeazsw kzxzfgjsrg (yqjaowzoka, vwevrbcmpg - tplkrrcuwg)
-
24 Aug 2023
(Standard of Care Arm)
jeqjbnvuge(bywypftupu) = vhofbzejat cqezppqvnj (gmuhnrjkcz, wlbvctpeyh - jrifdgyqmf)
Phase 1/2
60
(Phase A No LUM015)
jnectyapvl(onxpbulqov) = gkqlkeiddu hkvrpqiuow (rwkzmmmajw, 0.7)
-
05 Jan 2023
(Phase A 0.5 mg/kg)
jnectyapvl(onxpbulqov) = pnsfccgnxa hkvrpqiuow (rwkzmmmajw, 2.0)
Phase 1
9
vepfgfflmx(qbizrqvnkv) = ngkfxhmakp adtgogwrkx (jvqkdlcyda )
-
20 May 2014
vepfgfflmx(qbizrqvnkv) = fdjeugmgbn adtgogwrkx (jvqkdlcyda )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free